Warner Chilcott gains FDA nod for oral contraceptives

05/10/2013 | RTT News

The FDA has granted Warner Chilcott approval for its norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets. The oral contraceptives are expected to be released in August.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations